Topic: Genzyme Corporation
All Content
-
When patents kill: Genzyme's patent-protected, life-saving drug
Should intellectual property protect the rights of a pharmaceutical company who can't produce enough of a key medication?
-
Leadership comes from the locker room – even in stocks
For the market to move higher, some stocks have to become leaders, convincing investors they're convincing buys.
-
Warning: why cheaper money won't mean more jobs
Lowering the cost of capital will only help corporations with their wave of mergers and acquisitions, meaning more pink slips for everyone else.
Become part of the Monitor community